Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.

@article{Cumberbatch2018RepeatTR,
  title={Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.},
  author={Marcus George Kwesi Cumberbatch and Beat Foerster and James W. Catto and Ashish Madhav Kamat and Wassim Kassouf and Ibrahim Jubber and Shahrokh F Shariat and Richard Joel Sylvester and Paulo Gontero},
  journal={European urology},
  year={2018},
  volume={73 6},
  pages={
          925-933
        }
}
CONTEXT Initial treatment for most bladder cancers (BCs) involves transurethral resection (TUR) or tumours. Often more cancer is found after the initial treatment in around half of patients, requiring a second resection. Repeat transurethral resection (reTUR) is recommended for high-risk, non-muscle-invasive bladder cancer (NMIBC) to remove any residual disease and improve cancer outcomes. OBJECTIVE To systematically review the practice and therapeutic benefit of an early reTUR for high-risk… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 104 times. VIEW TWEETS